HLX07: Clinical Trials

12 trials of HLX07, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 unknown, 2 not yet recruiting, 1 recruiting. 12 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 212Unknown 9, Not yet recruiting 2, Recruiting 1
Phase 11Not yet recruiting 1
Phase 31Not yet recruiting 1

Follow HLX07: new trials by email Literature Review of HLX07 trials Research Report on HLX07

Trials (filtered) newest first · largest first

All 12 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase II/III Clinical Study to Evaluate HLX07 in Combination With Serplulimab and Chemotherapy Versus Placebo in Combination With Serplulimab or Pembrolizumab and Chemotherapy as First-Line Treatment in Advanced Squamous Non-Small Cell Lung Cancer
HLX07, HLX07 placebo, Serplulimab - Squamous NSCLC
Phase 2 / Phase 3Not yet recruitingShanghai Henlius Biotech7202026-03-012026-01-06
A Phase Ib/II Study to Evaluate HLX43 Combined With HLX07 or Serplulimab in Patients With Advanced or Metastatic Colorectal Cancer
HLX43 dose 1 + HLX07, HLX43 dose 2 + HLX07, HLX43 dose 3 + Serplulimab - Colon Cancer Adenocarcinoma
Phase 1 / Phase 2Not yet recruitingShanghai Henlius Biotech1262026-01-312026-01-22
A Phase II Clinical Study to Evaluate HLX43 in Subjects With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
HLX43 DOSE 1, HLX43 DOSE 2, HLX43 DOSE 3 - Carcinoma of Head and/or Neck
Phase 2RecruitingShanghai Henlius Biotech1672025-04-222026-03-05
A Clinical Study to Evaluate the Efficacy and Safety of HLX07 Combination Therapy in Patients With Extensive Small Cell Lung Cancer
HLX07, HLX10, carboplatin and etoposide - Small-cell Lung Cancer
Phase 2UnknownShanghai Henlius Biotech202023-03-292022-05-04
A Study to Evaluate the Efficacy and Safety of HLX07 in nsqNSCLC Patients With High EGFR Expression
HLX07+carboplatin+pemetrexed, HLX07+docetaxel, HLX07 - HLX07, nsqNSCLC, High EGFR Expression
Phase 2UnknownShanghai Henlius Biotech602023-02-012022-07-06
Phase II Clinical Study to Compare the Efficacy and Safety of HLX07 + Serplulimab +Chemotherapy Versus Placebo + Serplulimab + Chemotherapy in First-Line Treatment of Patients With Recurrent or Metastatic NPC
HLX07, HLX10, placebo - Nasopharyngeal Carcinoma by AJCC V8 Stage
Phase 2UnknownShanghai Henlius Biotech752022-12-142024-06-17
A Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX07 Combination Therapy or Monotherapy in Patients With Advanced ESCC
HLX07+HLX10+ Cisplatin+5-FU, HLX07 - ESCC or Esophageal Adenosquamous Carcinoma
Phase 2UnknownShanghai Henlius Biotech602022-08-252022-08-29
HLX07 Combination Therapy or Motherapy in Patient With Advanced Hepatocellular Carcinoma
HLX07, HLX10, HLX04 - Advanced Hepatocellular Carcinoma
Phase 2UnknownShanghai Henlius Biotech602022-08-012022-05-03
Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX07+HLX10 +mFOLFOX6 or HLX07 Monotherapy in Patients With mCRC
HLX07, HLX10, mFOLFOX6 - CRC
Phase 2UnknownShanghai Henlius Biotech502022-07-152022-05-03
The Efficacy and Safety of HLX07 in Locally Advanced or Metastatic Cutaneous Squamous Cell Carcinoma (CSCC)
HLX07 - Cutaneous Squamous Cell Carcinoma
Phase 2UnknownShanghai Henlius Biotech202022-06-152022-06-21
HLX07+HLX10+Chemotherapy or HLX07 Monotherapy in Patients With Advanced Metastatic Gastric Cancer
HLX07+HLX10+oxaliplatin+capecitabine, HLX07 - Gastric Cancer (GC) Gastroesophageal Junction Cancer (GEJ)
Phase 2UnknownShanghai Henlius Biotech402022-03-232022-05-02
Evaluate the Efficacy and Safety of HLX10 in Combination With HLX07 in Patients With Advanced Head and Neck Tumors
HLX10, HLX07, HLX07 placebo - Head and Neck Squamous Cell Carcinoma
Phase 2UnknownShanghai Henlius Biotech1312020-07-292023-08-08

Conditions studied

Colonic Neoplasms (1)  ·  Small Cell Lung Carcinoma (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)  ·  Stomach Neoplasms (1)

Sponsors

Shanghai Henlius Biotech (12)

Countries

China (10)

Top investigators

Chaosu Hu, Dr (1)  ·  Dongmei Ji (1)  ·  Guangyuan Hu (1)  ·  Guochun Cao (1)  ·  Jinming Yu (1)  ·  Man Hu, Dr (1)  ·  Meiyu Fang (1)  ·  Peng Junjie (1)  ·  Qingyuan Zhang (1)  ·  Shubin Wang (1)  ·  Wei Wang (1)  ·  Xiaohui He (1)  ·  Yan Sun (1)  ·  Ye Guo, PhD (1)

Results publications

PMID 39446605, PMID 40932107, PMID 42558795